5 FDA decisions to watch in the third quarter
Life-threatening consequences loom as cancer drug shortages grip the U.S.
Pfizer, citing safety concerns, scraps one of two obesity pill hopefuls
FDA discloses its first draft guidance on psychedelic trials
*please scroll down for all the latest news*
